Diagnostic efficacy and safety of 99mtc-labeled monoclonal antibody ior c5 in patients with colorectal and anal carcinomas: final report clinical trial phase I/II.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples